 BERLIN and BRISBANE, Australia, July 28, 2021 GLOBE NEWSWIRE -- atai Life Sciences atai or the Company Nasdaq: ATAI, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and UniQuest, Australias leading university technology transfer company commercializing the research of The University of Queensland UQ, today announced the launch of InnarisBio Inc. InnarisBio, to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. 